Aggregate Safety Reports Services

Freyr proficiently manages Aggregate Safety Reports Services, ensuring compliance with health authorities' requirements across the globe. We offer comprehensive services including customized template creation, aggregate report preparation, document management, review, submission, and health authority query handling for both pre-and post-approval phases.

Aggregate Safety Reports Services - Overview

To protect the safety and efficacy of a drug, the Marketing Authorization Holder (MAH) must conduct aggregate reporting in pharmacovigilance (PV) and safety medical writing activities. They must periodically submit aggregate safety reports, also known as a periodic report or a periodic safety report, to Health Authorities (HAs).

Based on the marketing authorization status, the MAH must prepare different types of reports, including pre-approval and post-marketing reports. These primarily include Periodic Benefit Risk Evaluation Reports (PBRER), Periodic Adverse Drug Experience Reports (PADER), and Development Safety Update Reports (DSUR). Additionally, many authorities also mandate submission of country specific annexes and local PSURs. Freyr’s Aggregate Safety Reports Services cater to all geographies and ensure compliance to regulatory requirements.

Pre-approval Aggregate Safety Reports

These aggregate safety reports include a cumulative summary of safety information for molecules under clinical development. These reports, such as the DSUR, focus on evaluation of safety information from nonclinical studies and safety data of subjects participating in clinical trials.

Development Safety Update Report (DSUR)

The DSUR document has replaced traditional reports such as Annual Safety Reports (ASRs) in Europe and Investigational New Drug (IND) annual reports in the United States. This harmonization ensures the three ICH regions receive information in the same format, thereby reducing the total number of reports generated. Sponsors are mandated to submit DSURs from the DIBD (development internation birth date) until all clinical studies are closed.

Post-approval Aggregate Safety Reports

These reports provide a cumulative summary of the company's core safety information for medicinal products that are approved/marketed.

The following types of aggregate reports are submitted for medicinal products post-marketing authorization:

  • Periodic Adverse Drug Experience Report (PADER)
  • Periodic Benefit Risk Evaluation Report (PBRER) or Periodic Safety Update Report (PSUR)
  • Summary Bridging Reports
  • Addendum to Clinical Overview reports
  • Safety Assessment Reports
  • Canadian Annual Safety Report documentation
  • Ad-hoc Reports (based on HA requests)

Strategic Implementation and Management

The following strategic-level maintenance activities are planned and executed by Freyr's team of experts as part of our comprehensive Aggregate Safety Reports Services:

  • Customised template creation and maintenance
  • Creation and maintenance of periodic report timetables and calendars
  • Literature management for aggregate report generation
  • Resource allocation based on expertise and skill set
  • Tracking and managing report preparation based on aggregate reporting periods and database lock
  • Preparation of line listings and tabulation
  • Medical review of draft documents
  • Submission to Health Authorities
  • Document management and archiving
  • Compliance with HA timelines
  • Handling and answering HA queries
  • SOP creation and maintenance

Aggregate Safety Reports Services

  • Qualified experts (medical doctors, pharmacy, and life sciences graduates) with domain knowledge and relevant experience
  • Support with creation and maintenance of aggregate reporting schedules per product DIBD, IBD, and EURD list
  • Support with creation and maintenance of templates for reports, tracking and metric generation
  • Development of complex reports such as PBRER, PSUR, and DSUR documentation
  • Expertise in handling various report types including ACOs, IND Annual Reports, Canada Annual Reports, Local PSURs, and SSURs for both development and post-authorization phases
  • Language translation capabilities for local safety report
Safety-Aggregate-Reporting-Services
  • Robust documented processes governing periodic report management, customizable per client requirements
  • Design and implementation of technology, templates, and procedures required for effective aggregate reporting in pharmacovigilance
  • Quality management processes ensuring high-quality deliverables
  • Expert review by experienced medical doctors to ensure accuracy and consistency of scientific interpretations
  • In-house publishing and submission teams ensuring seamless delivery and compliance
Safety-Aggregate-Reporting-Services-advantages

Simplify your aggregate report preparation and submission process with our expert services